Tricyclic antidepressants (TCAs) are a group of drugs used to treat affective, or ‘mood’, disorders. Side effects of the TCAs include sedation, caused by histamine H1 receptor blockade; postural hypotension, due to α adrenoreceptor blockade; and blurred vision, dry mouth and constipation, due to muscarinic acetylcholine receptor blockade.1
Click here: Discover the role of tricyclic antidepressants in depression treatment
Related content
This slide deck summarizes the current knowledge surrounding the use of psychedelics for the treatment of depression. Specifically, our focus centers on serotonergic psychedelics, commonly referred to as classical psychedelics. These psychedelics primarily function as agonists or partial agonists at the serotonin 2A receptor (5-HT2A receptor).
The infographic shows a 27% increase in depression cases due to COVID-19, affecting 280 million people worldwide.
Dr. Jasmina Mallet highlights the latest research in psychiatric genetics, emphasizing the role of Polygenic Risk Scores (PRS) in psychiatry.